Search

Societal Impact Statement Plants are living repositories of pharmacologically active chemicals and help to meet society's health care needs directly, or by providing natural products for drug development. We describe phylogenetic approaches to compare medicinal floras from different cultures in distinct regions of the world, and consider how these findings can improve knowledge of how plants have been selected for medical purposes. Greater insight into how people have selected plants for medicinal use will benefit healthcare and drug discovery strategies, and ultimately contribute to the future health and well‐being of society. Summary Four medicinal floras were compared using phylogenetic methods, to test whether there are shared patterns in medical plant use at the level of the whole medicinal floras, or for specific therapeutic applications. Checklists of the native plants and medicinal plants of Oman were compiled, and analyzed alongside existing checklists for Nepal, the Cape of South Africa and New Zealand. We reconstructed a plant phylogeny at generic level for Oman, and a new, more inclusive phylogeny to represent the genera found in all four local floras. Methods from community phylogenetics were used to identify clustering and overdispersion of the plants used. The impacts of using local or more inclusive phylogenies and different null model selections were explored. We found that Omani medicinal plant use emphasizes the same deep lineages of flowering plants as the other three medicinal floras, most strongly when comparing Omani and Nepalese medicinal plants. Drivers of this similarity might be floristic composition, opportunity for exchange of knowledge and shared beliefs in the causation of illness. Phylogenetic patterns among therapeutic applications are cross‐predictive within and between cultures, and must be interpreted with care since inappropriate use of null models can result in spurious similarity. High levels of cross‐predictivity suggest that targeting plants used for specific therapeutic applications to identify specific bioactives may have limited value. We outline the questions that might be addressed using a global phylogeny and medicinal plant checklists, suggest the best methods for future studies and propose how findings might be interpreted.

Retracing pathways of historical species introductions is fundamental to understanding the factors involved in the successful colonization and spread, centuries after a species' establishment in an introduced range. Numerous plants have been introduced to regions outside their native ranges both intentionally and accidentally by European voyagers and early colonists making transoceanic journeys; however, records are scarce to document this. We use genotyping-by-sequencing and genotype-likelihood methods on the selfing, global weed

Bioprospecting is the search for valuable products from natural sources. Given that most species are poorly known, a key question is where to search. Ethnodirected bioprospecting approaches use traditional knowledge in the process of selecting plants to screen for desired properties. A complementary approach is to utilize phylogenetic analyses based on traditional uses or known chemistry to identify lineages in which desired properties are most likely to be found. Novel discoveries of plant bioactivity from these approaches can aid the development of treatments for diseases with unmet medical needs. For example, neurological disorders are a growing concern, and psychoactive plants used in traditional medicine may provide botanical sources for bioactivity relevant for treating diseases related to the brain and nervous system. However, no systematic study has explored the diversity and phylogenetic distribution of psychoactive plants. We compiled a database of 501 psychoactive plant species and their properties from published sources. We mapped these plant attributes on a phylogenetic tree of all land plant genera and showed that psychoactive properties are not randomly distributed on the phylogeny of land plants; instead certain plant lineages show overabundance of psychoactive properties. Furthermore, employing a ‘hot nodes’ approach to identify these lineages, we can narrow down our search for novel psychoactive plants to 8.5% of all plant genera for psychoactivity in general and 1–4% for specific categories of psychoactivity investigated. Our results showcase the potential of using a phylogenetic approach to bioprospect plants for psychoactivity and can serve as foundation for future investigations.

[Ethnopharmacological relevance] The discovery of the antimalarial agent artemisinin is considered one of the most significant success stories of ethnopharmacological research in recent times. The isolation of artemisinin was inspired by the use of Artemisia annua in traditional Chinese medicine (TCM) and was awarded a Nobel Prize in 2015. Antimalarial activity has since been demonstrated for a range of other Artemisia species, suggesting that the genus could provide alternative sources of antimalarial treatments. Given the stunning diversity of the genus (c. 500 species), a prioritisation of taxa to be investigated for their likely antimalarial properties is required., [Materials and methods] Here we use a phylogenetic approach to explore the potential for identifying species more likely to possess antimalarial properties. Ethnobotanical data from literature reports is recorded for 117 species. Subsequent phylogenetically informed analysis was used to identify lineages in which there is an overrepresentation of species used to treat malarial symptoms, and which could therefore be high priority for further investigation of antimalarial activity., [Results] We show that these lineages indeed include several species with documented antimalarial activity. To further inform our approach, we use LC-MS/MS analysis to explore artemisinin content in fifteen species from both highlighted and not highlighted lineages. We detected artemisinin in nine species, in eight of them for the first time, doubling the number of Artemisia taxa known to content this molecule., [Conclusions] Our findings indicate that artemisinin may be widespread across the genus, providing an accessible local resource outside the distribution area of Artemisia annua., This study was supported by the Marie Curie Actions of the 7th European Community Framework Programme: FP7/2007–2013, REA grant agreement no PIEF-GA-2012-328637-BiodiversityAltitude to C.H.S.L. and N.R. and 606895-MedPlant to N.R., as well as by the Agustí Pedro i Pons award 2012, Universitat de Barcelona, to E.C., and project 2014SGR514 of the Catalan government, project CGL2013-49097-C2-2-P of the Spanish government, and project 1-8/HEC/HRD/2013/2794 of the Pakistan government.

The current decrease of new drugs brought to the market has fostered renewed interest in plant-based drug discovery. Given the alarming rate of biodiversity loss, systematic methodologies in finding new plant-derived drugs are urgently needed. Medicinal uses of plants were proposed as proxy for bioactivity, and phylogenetic patterns in medicinal plant uses have suggested that phylogeny can be used as predictive tool. However, the common practice of grouping medicinal plant uses into standardised categories may restrict the relevance of phylogenetic predictions. Standardised categories are mostly associated to systems of the human body and only poorly reflect biological responses to the treatment. Here we show that medicinal plant uses interpreted from a perspective of a biological response can reveal different phylogenetic patterns of presumed underlying bioactivity compared to standardised methods of medicinal plant use classification. In the cosmopolitan and pharmaceutically highly relevant genus Euphorbia L., identifying plant uses modulating the inflammatory response highlighted a greater phylogenetic diversity and number of potentially promising species than standardised categories. Our interpretation of medicinal plant uses may therefore allow for a more targeted approach for future phylogeny-guided drug discovery at an early screening stage, which will likely result in higher discovery rates of novel chemistry with functional biological activity.

The global herbal products market has grown in recent years, making regulation of these products paramount for public healthcare. For instance, the common horsetail (Equisetum arvense L.) is used in numerous herbal products, but it can be adulterated with closely related species, especially E. palustre L. that can produce toxic alkaloids. As morphology-based identification is often difficult or impossible, the identification of processed material can be aided by molecular techniques. In this study, we explore two molecular identification techniques as methods of testing the purity of these products: a Thin Layer Chromatography approach (TLC-test) included in the European Pharmacopoeia and a DNA barcoding approach, used in recent years to identify material in herbal products. We test the potential of these methods for distinguishing and identifying these species using material from herbarium collections and commercial herbal products. We find that both methods can discriminate between the two species and positively identify E. arvense. The TLC-test is more cost- and time-efficient, but DNA barcoding is more powerful in determining the identity of adulterant species. Our study shows that, although DNA barcoding presents certain advantages, other established laboratory methods can perform as well or even better in confirming species’ identity in herbal products.

Ethnopharmacological relevance The genus Euphorbia (spurges, Euphorbiaceae) is the third largest genus of flowering plants, with almost 2000 species. Its exceptional diversity of growth forms and near-cosmopolitan distribution have attracted human interest since ancient times. For instance in Australia, topical application of latex of Euphorbia peplus L. is used as a home treatment for skin cancer and actinic keratosis. Its use in Australian folk medicine has inspired the release of the drug Picato® (ingenol mebutate), and further fostered interest in natural products and medicinal uses of Euphorbia in recent years. Aim of the study To provide an indicative overview of medicinal uses of the genus Euphorbia driven by the recent interest in biologically active natural products from Euphorbia in drug discovery. We assess documented medicinal knowledge and value of the genus Euphorbia and the taxonomic distribution of this value. Materials and methods We undertook an extensive survey of over 260 multidisciplinary publications on the online repository JSTOR using the search term “Euphorbia medicinal”. Results Medicinal uses were identified for >5% of the species in the genus, including descriptions of treatments for a variety of diseases. The most-cited medicinal uses around the world were treatments for digestive system disorders, skin ailments and, especially in the Southern hemisphere, infections. Consensus ratios indicated that the most-valued medicinal uses of Euphorbia species are in the treatment of digestive and respiratory complaints, inflammation and injuries, especially by members of Euphorbia subg. Chamaesyce. Conclusions The present study gives a first indicative overview of Euphorbia species used for health and wellbeing around the world. The exceptional diversity of the genus Euphorbia is not only represented by its growth forms but also by its diverse medicinal uses. Our results highlight the importance of research into medicinal uses of Euphorbia species and their importance as a source of natural products. Furthermore the medicinally highly valuable subgenus Chamaesyce was identified as chemically under-investigated, emphasizing the need for further studies investigating the chemical diversity to which the high medicinal value of Euphorbia subg. Chamaesyce can be attributed.

Phylogenies reconstruct species’ evolutionary relationships and phylogenetic methods provide a comparative framework when traits correlate with evolutionary relationships. This study reviews the applications of these methods in ethnobiological research, particularly ethnobotany and ethnopharmacology. We discuss the advantages of phylogenetic methods for the exploration of medicinal plant diversity and cross-cultural ethnobiology. We conclude that, despite current limitations, phylogenies can be used to reveal and interpret patterns of traditional use of plants and bring together the fields of ethnobiology and pharmacology, synthesising biochemical, pharmacological and ethnopharmacological data. The evolutionary approach to ethnobiology will require further collaboration between evolutionary biologists and ethnobiologists to answer long-standing questions about the relationship of humans with the natural environment.

There is controversy about whether traditional medicine can guide drug discovery, and investment in bioprospecting informed by ethnobotanical data has fluctuated. One view is that traditionally used medicinal plants are not necessarily efficacious and there are no robust methods for distinguishing those which are most likely to be bioactive when selecting species for further testing. Here, we reconstruct a genus-level molecular phylogenetic tree representing the 20,000 species found in the floras of three disparate biodiversity hotspots: Nepal, New Zealand, and the Cape of South Africa. Borrowing phylogenetic methods from community ecology, we reveal significant clustering of the 1,500 traditionally used species, and provide a direct measure of the relatedness of the three medicinal floras. We demonstrate shared phylogenetic patterns across the floras: related plants from these regions are used to treat medical conditions in the same therapeutic areas. This finding strongly indicates independent discovery of plant efficacy, an interpretation corroborated by the presence of a significantly greater proportion of known bioactive species in these plant groups than in random samples. We conclude that phylogenetic cross-cultural comparisons can focus screening efforts on a subset of traditionally used plants that are richer in bioactive compounds, and could revitalize the use of traditional knowledge in bioprospecting.

ISSN 1948‐6596 news and update The final talk in the session, presented by Leticia Ochoa‐Ochoa, used the golden toad story (Bufo periglenes) as a case study to evaluate how some science stories influence the media, and peoples’ resulting perception of biodiversity loss. She and her colleagues explored the emergence of the words “biodiversity crisis,” in the media from the 1987 to 1992, and suggest that the toad was instrumental in shifting society’s perception of biodiversity loss. More broadly, they emphasized that conservation biogeographers (and conserva‐ tion biologists in general) know little about how the media perceives their work and the impact it could have on societal views towards the conser‐ vation of biological diversity. In summary, these talks touched on many of the themes and challenges to conservation bio‐ geography outlined by Ladle and Whittaker (2011). A critical challenge is to implement and disseminate the new knowledge and tools to con‐ servation practitioners and the public. Catherine H. Graham 1 & Leone M. Brown 2 Department of Ecology and Evolution, Stony Brook University, New York, USA. e‐mails: 1 cgraham@life.bio.sunysb.edu, lbrown@life.bio.sunysb.edu; http://life.bio.sunysb.edu/ee/ grahamlab/ References Ladle, R.J. & Whittaker, R.J., eds. (2011). Conservation Biogeography. Wiley‐Blackwell, Oxford. Whittaker, R.J., Araujo, M.B., Paul, J., Ladle, R.J., Wat‐ son, J.E.M. & Willis, K.J. (2005). Conservation Biogeography: assessment and prospect. Diver‐ sity and Distributions, 11, 3‐23. Edited by Michael N Dawson symposium summary Hot topics in biogeography and ecology A contributed session at the 5th International Biogeography Society Conference – Heraklion, Greece, 7–11 January 2011 The “hot topics” session of the Meeting of the In‐ ternational Biogeography Society (IBS) aimed to highlight new developments and ideas in the field of biogeography. While there was no pre‐ determined theme linking the presentations, sev‐ eral topics were raised by several presentations during the session. For example, it was apparent that molecular data have become increasingly in‐ strumental to furthering our understanding of bio‐ geography, including distribution patterns, disper‐ sal routes, historic events, ecological trait varia‐ tion and community assembly. In addition, multid‐ isciplinary studies (e.g. drawing data from ecology, morphology, climatology, geology, species distri‐ butions and molecular phylogenies) employing recent methodological advances were shown to provide a deeper understanding of several long‐ standing questions in biogeography and mac‐ roecology. Here, we summarize the presentations that made up the session and attempt to highlight their significance. In recent years it has become increasingly apparent that long‐distance dispersal events are responsible for the disjunct distributions of many organismal groups (de Queiroz 2005). What have been less explored are the factors that facilitate such dispersal—and subsequent colonization— events. Peter Linder and colleagues used a dated phylogeny of danthonioid grasses to infer their long‐distance dispersal routes. This allowed them to explore the effects of factors such as dispersal distance, prevailing wind direction, the nature of dispersal routes and the age of source areas on the probability of long‐distance colonization events, of which the age was the main explana‐ tory factor. The field of community phylogenetics (Webb et al. 2002) has provided novel tools to recover patterns in ecology and species distribu‐ tion. Employing such tools, Catherine Graham and colleagues presented their work on patterns of morphological variation in hummingbirds across © 2011 the authors; journal compilation © 2011 The International Biogeography Society — frontiers of biogeography 3.1, 2011

BackgroundThe study of traditional knowledge of medicinal plants has led to discoveries that have helped combat diseases and improve healthcare. However, the development of quantitative measures that can assist our quest for new medicinal plants has not greatly advanced in recent years. Phylogenetic tools have entered many scientific fields in the last two decades to provide explanatory power, but have been overlooked in ethnomedicinal studies. Several studies show that medicinal properties are not randomly distributed in plant phylogenies, suggesting that phylogeny shapes ethnobotanical use. Nevertheless, empirical studies that explicitly combine ethnobotanical and phylogenetic information are scarce.Methodology/principal findingsIn this study, we borrowed tools from community ecology phylogenetics to quantify significance of phylogenetic signal in medicinal properties in plants and identify nodes on phylogenies with high bioscreening potential. To do this, we produced an ethnomedicinal review from extensive literature research and a multi-locus phylogenetic hypothesis for the pantropical genus Pterocarpus (Leguminosae: Papilionoideae). We demonstrate that species used to treat a certain conditions, such as malaria, are significantly phylogenetically clumped and we highlight nodes in the phylogeny that are significantly overabundant in species used to treat certain conditions. These cross-cultural patterns in ethnomedicinal usage in Pterocarpus are interpreted in the light of phylogenetic relationships.Conclusions/significanceThis study provides techniques that enable the application of phylogenies in bioscreening, but also sheds light on the processes that shape cross-cultural ethnomedicinal patterns. This community phylogenetic approach demonstrates that similar ethnobotanical uses can arise in parallel in different areas where related plants are available. With a vast amount of ethnomedicinal and phylogenetic information available, we predict that this field, after further refinement of the techniques, will expand into similar research areas, such as pest management or the search for bioactive plant-based compounds.

Ethnopharmacological relevance One of the major drawbacks of using ethnomedicinal data to direct testing of plants which may find pharmaceutical use is that certain plants without bioactivity might be traditionally used. An accepted way of highlighting bioactive plants is to compare usage in different cultures. This approach infers that presumed independent discovery by different cultures provides evidence for bioactivity. Although several studies have made cross-cultural comparisons, they focussed on closely related cultures, where common patterns might be the result of common cultural traditions. The aim of this study was to compare three independent ethnomedicinal floras for which similarities can be more robustly interpreted as independent discoveries, and therefore likely to be indication for efficacy. Materials and methods Data from the literature were compiled about the ethnomedicinal floras for three groups of cultures (Nepal, New Zealand and the Cape of South Africa), selected to minimise historical cultural exchange. Ethnomedicinal applications were divided in 13 categories of use. Regression and binomial analyses were performed at the family level to highlight ethnomedicinal “hot” families. General and condition-specific analyses were carried out. Results from the three regions were compared. Results Several “hot” families (Anacardiaceae, Asteraceae, Convolvulaceae, Clusiaceae, Cucurbitaceae, Euphorbiaceae, Geraniaceae, Lamiaceae, Malvaceae, Rubiaceae, Sapindaceae, Sapotaceae and Solanaceae) were recovered in common in the general analyses. Several families were also found in common under different categories of use. Conclusions Although profound differences are found in the three ethnomedicinal floras, common patterns in ethnomedicinal usage are observed in widely disparate areas of the world with substantially different cultural traditions. As these similarities are likely to stem from independent discoveries, they strongly suggest that underlying bioactivity might be the reason for this convergent usage. The global distribution of prominent usage of families used in common obtained by this study and the wider literature is strong evidence that these families display exceptional potential for discovery of previously overlooked or new medicinal plants and should be placed in high priority in bioscreening studies and conservation schemes.

Evolutionary biologists and ecologists increasingly appreciate the value of local knowledge of human communities for research into the past, present, and future of biodiversity [1–3]. However, there are often significant problems accessing and interpreting this knowledge [3]. Here, we argue that closer interaction with ethnobiologists, who study the relation between humans and the natural world, will enable local knowledge to be better applied in ecological and evolutionary biological research. This will provide more comprehensive answers to the scientific questions being asked, and will result in improved engagement with both academic and non-academic communities.

Traditional knowledge is influenced by ancestry, inter-cultural diffusion and interaction with the natural environment. It is problematic to assess the contributions of these influences independently because closely related ethnic groups may also be geographically close, exposed to similar environments and able to exchange knowledge readily. Medicinal plant use is one of the most important components of traditional knowledge, since plants provide healthcare for up to 80% of the world's population. Here, we assess the significance of ancestry, geographical proximity of cultures and the environment in determining medicinal plant use for 12 ethnic groups in Nepal. Incorporating phylogenetic information to account for plant evolutionary relatedness, we calculate pairwise distances that describe differences in the ethnic groups' medicinal floras and floristic environments. We also determine linguistic relatedness and geographical separation for all pairs of ethnic groups. We show that medicinal uses are most similar when cultures are found in similar floristic environments. The correlation between medicinal flora and floristic environment was positive and strongly significant, in contrast to the effects of shared ancestry and geographical proximity. These findings demonstrate the importance of adaptation to local environments, even at small spatial scale, in shaping traditional knowledge during human cultural evolution.

Bui's commentary [[1][1]] arises from an observation made in our paper on the evolution of salt tolerance in grasses. We described the ‘paradox’ of salt tolerance; that it evolves often in nature but is hard to breed into crops [[2][2]], although there has been recent success in increasing the